This is a demo store. No orders will be fulfilled.

Risarestat - 98%, high purity , CAS No.79714-31-1

    Grade & Purity:
  • ≥98%
In stock
Item Number
R647182
Grouped product items
SKU Size
Availability
Price Qty
R647182-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$500.90
R647182-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$850.90
R647182-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,800.90
R647182-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$3,000.90
R647182-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$4,600.90

Basic Description

Synonyms 5-[3-ethoxy-4-(pentyloxy)phenyl]-2,4-thiazolidinedione | SCHEMBL1814433 | HY-16433 | CAS-79714-31-1 | Q27088451 | Risarestat | MS-24804 | 5-(3-Ethoxy-4-(pentyloxy)phenyl)-2,4-thiazolidinedione | 5-(3-ethoxy-4-pentoxyphenyl)-1,3-thiazolidine-2,4-dione | CS
Specifications & Purity ≥98%
Biochemical and Physiological Mechanisms Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.
Storage Temp Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.

In Vivo

Risarestat inhibits the accumulation of dulcitol in a dose-dependent manner, except for the 1.0% solution which has an activity comparable to the 0.25% solution . Risarestat peaks in the corneal epithelium, stroma, endothelium and aqueous humor in 30 minutes following instillation, then gradually diminishes time-dependently over a period of 24 hours. Risarestat remains detectable in the lens up to 24 hours, with a peak concentration at 2 hours after instillation. The anterior surface area of superficial cells in the group treated with Risarestat is significantly decreases from a mean value of 881 to 728 microns 2 . Corneal sensitivity significantly improves from 5.36 to 1.37 g/mm 2. Animals treated with Risarestat shows a significant increase in the mean blinkresponse compared to untreated galactose-fed rats and does not differ significantly from controls towards the completion of the 7 month study. Animals treated topically with Risarestat and untreated galactose-fed rats develop bilateral nuclear cataracts within 3 weeks. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Benzenoids
Class Phenol ethers
Subclass Not available
Intermediate Tree Nodes Not available
Direct Parent Phenol ethers
Alternative Parents Phenoxy compounds  Thiazolidinediones  Alkyl aryl ethers  Dicarboximides  Thiocarbamic acid derivatives  Organic carbonic acids and derivatives  Azacyclic compounds  Organopnictogen compounds  Organonitrogen compounds  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular Framework Aromatic heteromonocyclic compounds
Substituents Phenoxy compound - Phenol ether - Alkyl aryl ether - Thiazolidinedione - Monocyclic benzene moiety - Dicarboximide - Thiazolidine - Thiocarbamic acid derivative - Carbonic acid derivative - Organoheterocyclic compound - Ether - Carboxylic acid derivative - Azacycle - Organic oxide - Organopnictogen compound - Organooxygen compound - Organonitrogen compound - Organic nitrogen compound - Carbonyl group - Organic oxygen compound - Hydrocarbon derivative - Aromatic heteromonocyclic compound
Description This compound belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.
External Descriptors Not available

Associated Targets(non-human)

Luciferin 4-monooxygenase (66902 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Names and Identifiers

IUPAC Name 5-(3-ethoxy-4-pentoxyphenyl)-1,3-thiazolidine-2,4-dione
INCHI InChI=1S/C16H21NO4S/c1-3-5-6-9-21-12-8-7-11(10-13(12)20-4-2)14-15(18)17-16(19)22-14/h7-8,10,14H,3-6,9H2,1-2H3,(H,17,18,19)
InChIKey CRPGRUONUFDYBG-UHFFFAOYSA-N
Smiles CCCCCOC1=C(C=C(C=C1)C2C(=O)NC(=O)S2)OCC
Isomeric SMILES CCCCCOC1=C(C=C(C=C1)C2C(=O)NC(=O)S2)OCC
Alternate CAS 79714-31-1
PubChem CID 133264
MeSH Entry Terms 5-(3-ethoxy-4-pentyloxyphenyl)-2,4-thiazolidinedione;CT 112;CT-112;risarestat
Molecular Weight 323.41

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

Solubility DMSO : 105 mg/mL (324.67 mM; Need ultrasonic)
Molecular Weight 323.400 g/mol
XLogP3 3.900
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 8
Exact Mass 323.119 Da
Monoisotopic Mass 323.119 Da
Topological Polar Surface Area 89.900 Ų
Heavy Atom Count 22
Formal Charge 0
Complexity 390.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 1
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.